Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

NCT04577820 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Phase 2 Study R2477-FOP-1940 has been withdrawn and the next phase of the development program is being planned

Conditions

Interventions

Sponsor

Regeneron Pharmaceuticals